Geode Capital Management LLC Has $213,000 Holdings in Allurion Technologies Inc. (NYSE:ALUR)

Geode Capital Management LLC lessened its holdings in Allurion Technologies Inc. (NYSE:ALUR) by 4.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 495,788 shares of the company’s stock after selling 20,542 shares during the quarter. Geode Capital Management LLC owned 19.14% of Allurion Technologies worth $213,000 as of its most recent SEC filing.

Analysts Set New Price Targets

ALUR has been the topic of several analyst reports. Chardan Capital reissued a “neutral” rating and set a $2.50 price target on shares of Allurion Technologies in a research report on Thursday, March 27th. Roth Mkm reiterated a “buy” rating and set a $16.00 target price on shares of Allurion Technologies in a report on Friday, March 21st.

Allurion Technologies Trading Down 2.6 %

NYSE ALUR opened at $2.27 on Friday. The firm has a market capitalization of $10.88 million, a P/E ratio of -0.19 and a beta of -0.61. The firm’s fifty day moving average price is $2.66 and its two-hundred day moving average price is $7.15. Allurion Technologies Inc. has a 1 year low of $2.15 and a 1 year high of $88.75.

Allurion Technologies (NYSE:ALUR) last issued its earnings results on Wednesday, March 26th. The company reported ($7.00) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($5.00) by ($2.00). The firm had revenue of $5.59 million for the quarter, compared to the consensus estimate of $5.60 million. On average, research analysts anticipate that Allurion Technologies Inc. will post -9.96 EPS for the current fiscal year.

Insider Transactions at Allurion Technologies

In related news, CEO Shantanu Gaur bought 8,000 shares of the business’s stock in a transaction dated Friday, March 28th. The stock was bought at an average price of $3.35 per share, for a total transaction of $26,800.00. Following the purchase, the chief executive officer now owns 8,000 shares in the company, valued at $26,800. This represents a ∞ increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 22.40% of the stock is currently owned by corporate insiders.

Allurion Technologies Company Profile

Allurion Technologies Inc focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite.